Luke Archibald, MD

Assistant Professor of Biomedical Data Science and Psychiatry, Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College

Dr. Luke Archibald joined Dartmouth-Hitchcock as the Director of Addiction Services in the Department of Psychiatry in November 2018. In addition to this position, Dr. Archibald is also the medical director of the Dartmouth-Hitchcock Addiction Treatment Program (ATP). The services include an Intensive Outpatient Program (IOP), medical visits for hundreds of individuals with Opioid Use Disorder (OUD), and a Perinatal Addiction Treatment Program (PATP), and it is the site of the regional hub for the New Hampshire State Opioid Response (SOR) Doorway project. Previously, he worked in the NYU School of Medicine, serving as the Director of the Addiction Division in the Department of Psychiatry at Bellevue Hospital. In that role, he oversaw three clinical programs: the Opioid Treatment Program (OTP), the Chemical Dependency Outpatient Program (CDOP), and the inpatient detoxification and stabilization unit. In addition, Dr. Archibald has served as a lead in planning Bellevue Hospital’s Consult for Addiction Treatment and Care in Hospitals (CATCH) program, part of New York City Health and Hospital’s Healing NYC effort to combat the opioid epidemic. Other direct clinical responsibilities included the role of unit chief of Bellevue’s inpatient dual diagnosis service. Advancing treatment for substance use disorders through carefully conducted research has been an important mission in all of these sites. Dr. Archibald cares deeply about providing the highest quality, most compassionate, and easily accessible treatment for individuals with substance use disorders and other mental health conditions, both directly and through developing and advancing clinical programs and teaching.